Sign in

CIK 0001662774 · Non-accelerated filer<br>Smaller reporting company

IRulya Therapeutics Inc.

Sign in to watch
Ticker
IRLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
901024039
Phone
203-208-8994
Business address
101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
Former names
Quince Therapeutics, Inc., Cortexyme, Inc.
  1. 8-K Event Results of operations
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 10-Q Report Quarterly Report
  6. 8-K Event Results of operations
  7. SC 13G/A Stake Amended Statement of Ownership
  8. 8-K Event Delisting notice
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 8-K Event Shareholder vote results
  17. 4 Insider Changes in Ownership
  18. 10-Q Report Quarterly Report
  19. ARS Other Annual Report to Security Holders
  20. DEFA14A Proxy Proxy Materials

Page 8 of 24 · 467 filings